Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Vir Biotechnology, Inc.

CIK 1706431 VIR·Biological Products · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

Vir Biotechnology, Inc. cited accounting standard ASU 2023-06 for the first time in this filing series

The Company adopted ASU 2023-06 in this Annual Report on Form 10-K on a prospective basis.
Evidence
Adopted
2023-06
Contexts
The Company adopted ASU 2023-06 in this Annual Report on Form 10-K on a prospective basis.
New standards
2023-06, 2025-06, 2025-07
Prior filed
2025-02-27
Prior form
10-K
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.